Texas has initiated a legal action against Johnson & Johnson, the manufacturer of Tylenol, over allegations that the company did not adequately inform pregnant women about potential risks associated with the medication and autism.
The lawsuit references recent scientific findings suggesting that acetaminophen, the active ingredient in Tylenol, can pose risks to unborn children. It claims the company “misrepresents Tylenol as the only safe pain relief option for pregnant women,” which may violate Texas consumer protection laws.
As outlined in the lawsuit:
The growing scientific evidence linking acetaminophen exposure during pregnancy to conditions such as autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) suggests that Johnson & Johnson was aware of the risks. Instead of assuming responsibility, the company allegedly transferred liabilities related to Tylenol to Kenvue, Inc. and Kenvue Brands LLC, in violation of Texas law designed to prevent fraudulent transfers, to shield their assets from affected families.
The lawsuit also refers to a warning letter sent by members of the Trump administration, including Health and Human Services Secretary Robert F. Kennedy Jr., who stated that Donald Trump linked Tylenol use during pregnancy to an elevated risk of autism.
Lawsuit specifics:
Recently, the federal government confirmed what has been suspected for years: using acetaminophen while pregnant increases the likelihood of ASD and ADHD. Given acetaminophen’s widespread use and the commonality of these conditions, the defendants might face substantial financial repercussions due to the harm caused to children. However, because of these alleged fraudulent transfers, there could be insufficient funds to compensate victims in Texas.
Despite acetaminophen being the sole active ingredient in Tylenol, studies show that it can contribute to ASD and ADHD when taken by mothers during pregnancy. At least 26 studies have found a correlation between prenatal acetaminophen use and these developmental disorders. Six of those studies specifically explored the dose-response relationship for ADHD, and two focused on ASD; all indicated a correlation.
Texas Attorney General Ken Paxton remarked, “Big Pharma has let down America by profiting from pain while ignoring risks associated with their drugs.” He further added, “These companies have deceived the public for years and exposed millions to danger. As they face potential bankruptcy, Johnson & Johnson allegedly tried to evade accountability by transferring blame to another entity. Our fight is to hold them accountable and promote public health.”
This lawsuit comes on the heels of a statement made by President Trump in September, which noted that the FDA will inform healthcare providers about the significant autism risk related to acetaminophen usage during pregnancy. He emphasized that taking Tylenol can pose risks and recommended limiting its use during pregnancy unless absolutely necessary.
A related old post from Tylenol’s social media account went viral, where the company stated in 2017, “We do not recommend using our products during pregnancy. Thank you for your concerns.” Additionally, a document from June 2019 noted, “we do not test Tylenol for use during pregnancy.”
